Benzodiazepine Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Benzodiazepine Drugs Market Overview and it is segmented by Products (Alprazolam, Diazepam, Lorazepam, Clonazepam), Application, Time of Action, and Geography.

Benzodiazepine Drugs Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Benzodiazepine Drugs Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 2.40 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Benzodiazepine Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Benzodiazepine Drugs Market Analysis

The benzodiazepine drugs market studied was anticipated to grow with a CAGR of 2.4%, during the forecast period. Benzodiazepines are a class of psychoactive drugs that are used to treat diseases like anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. Benzodiazepine drugs produce a calming effect by enhancing the effect of the neurotransmitter GABA (Gamma-Aminobutyric Acid). Benzodiazepines drugs are widely prescribed drugs across the world and are helpful to reduce anxiety disorders, seizures, inducing sleep and also used for sedation purposes prior to surgery or general anesthesia. Rise in the geriatric population, stressful lifestyle, daily habits are major factors for mental disturbance, which creates anxiety, maniac, and panic disorder conditions. The market for benzodiazepine drugs is expanding rapidly due to an increase in the prevalence of anxiety, seizures, insomnia, and a rise in concern for the prevention of stress and related conditions. Alprazolam segment is anticipated to expand growth due to its wide application in anxiety, panic disorders. However, misuse of benzodiazepine drugs may restrict the growth of this market.

Benzodiazepine Drugs Market Trends

This section covers the major market trends shaping the Benzodiazepine Drugs Market according to our research experts:

Anxiety Disorders Segment is Expected to Hold a Largest Market Share in the Benzodiazepine Drugs

Anxiety segment is anticipated to account for major share of the market during the forecast period.According to World Health Organization (WHO) estimated number of people living with anxiety disorders globally is 264 million in the year 2015 reflects a 14.9% increase since 2005, as a result of population growth and ageing and which is estimated to be 3.6%. Anxiety disorders are more common among females than males (4.6% in females compared to 2.6% in males at the global level).

In 2017, anxiety segment recorded more than 60% revenue share collectively with anti-depressants drugs and the boost in demand for anxiety therapeutics coupled with a rise in a number of companies investing to develop new anxiety drugs which drives the market revenue. Anxiety was a dominant segment of the benzodiazepines drug market globally in the year 2017 and expected to maintain same during the forecast period.

Benzodiazepine Drugs Market - Stress Level in GenZ Adults, (on Scale of 1 to 10), United States, 2018-2020

North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period

North America is expected to hold a dominating position in the global benzodiazepine drugs market due to more FDA approvals in that region. Around 40 million adults in the United States are affected every year with anxiety disorders of which only 36.9% receive treatment according to Anxiety and Depression Association of America (ADAA). Increase in the development of mental health-care services and rising awareness towards anxiety disorders are responsible for the increase in the diagnosis of generalized anxiety disorder (GAD). Due to growth in geriatric population is increasing the anxiety diagnosis rates in Mexico, thus directly boosting the demand for physiotherapies such as Cognitive Behavior Therapy (CBT) and generalized anxiety disorder (GAD) medication.

Benzodiazepine Drugs Market-Geography

Benzodiazepine Drugs Industry Overview

The Benzodiazepine Drugs Market is moderately competitive and consists of several players. In terms of market share, more number of the players are currently dominating the market. Some of the companies which are currently dominating the market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma among others.

Benzodiazepine Drugs Market Leaders

  1. Pfizer Inc.

  2. F. Hoffmann-La Roche Ltd

  3. Bausch Health Companies, Inc

  4. Mylan N.V.

  5. Teva Pharmaceutical Industries Ltd

*Disclaimer: Major Players sorted in no particular order

Benzodiazepine Drugs Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Benzodiazepine Drugs Market News

In September 2020, in Japan, Taisho Pharmaceutical Co., Ltd., initiated a phase II clinical trial to assess the efficacy of TS-142 in the treatment of insomnia. The trial is expected to complete in December 2021.

In February 2020, United States Food and Drug Administration provided approval to Merck for its Belsomra drug in the treatment of insomnia in patients with mild-to-moderate Alzheimer's disease.

Benzodiazepine Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Anxiety disorders, Seizures and Insomnia Diseases
    • 4.2.2 Rise in Adoption of Generic Drugs
  • 4.3 Market Restraints
    • 4.3.1 Misuse of Benzodiazepine Drugs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Alprazolam
    • 5.1.2 Diazepam
    • 5.1.3 Lorazepam
    • 5.1.4 Clonazepam
  • 5.2 By Application
    • 5.2.1 Anxiety disorders
    • 5.2.2 Seizures
    • 5.2.3 Insomnia
    • 5.2.4 Alcohol Withdrawal
  • 5.3 By Time of Action
    • 5.3.1 Ultra-short Acting
    • 5.3.2 Short Acting
    • 5.3.3 Long Acting
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amneal Pharmaceuticals LLC
    • 6.1.2 Apotex Inc.
    • 6.1.3 Aurobindo Pharma
    • 6.1.4 Bausch Health Companies, Inc.
    • 6.1.5 F.Hoffmann-La Roche Ltd.
    • 6.1.6 H.Lundbeck A/S
    • 6.1.7 Mylan, N.V.
    • 6.1.8 Pfizer Inc.
    • 6.1.9 Sun Pharmaceutical Industries Ltd.
    • 6.1.10 Teva Pharmaceutical Industries Ltd.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Benzodiazepine Drugs Industry Segmentation

Benzodiazepines is a class of psychoactive drugs that are used to treat diseases like anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. Benzodiazepine drugs are segmented by Products, Application, Time of Action and Geography.

By Product Alprazolam
Diazepam
Lorazepam
Clonazepam
By Application Anxiety disorders
Seizures
Insomnia
Alcohol Withdrawal
By Time of Action Ultra-short Acting
Short Acting
Long Acting
Geography North America United States
Canada
Mexico
Geography Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Geography Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
Geography South America Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Benzodiazepine Drugs Market Research FAQs

The Benzodiazepine Drugs Market is projected to register a CAGR of 2.40% during the forecast period (2024-2029)

Pfizer Inc., F. Hoffmann-La Roche Ltd, Bausch Health Companies, Inc, Mylan N.V. and Teva Pharmaceutical Industries Ltd are the major companies operating in the Benzodiazepine Drugs Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Benzodiazepine Drugs Market.

The report covers the Benzodiazepine Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Benzodiazepine Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Benzodiazepine Drugs Industry Report

Statistics for the 2023 Benzodiazepine Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Benzodiazepine Drugs analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Benzodiazepine Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)